ABSTRACT. Leukotriene (LT) C4 or D4 may mediate pulmonary hypertension induced by hypoxia. LT have also been isolated from patients with persistent pulmonary hypertension of the newborn syndrome and the adult respiratory distress syndrome. To compare the effects of LTC4 and D4 on the pulmonary and systemic circulations, we performed dos4response studies on spontaneously breathing newborn lambs. To determine whether the hemodynamic effects of LT are mediated through a-adrenergic stimulation, some lambs were pretreated with the a-adrenergic antagonist phentolamine mesylate before LT injection. These results were com~ared to the effects of retreatment with the LT receptor &tagonist F~~5 7 2 3 i .
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To determine whether the LT-induced decrease in cardiac output was mediated by the decrease in heart rate, other lambs had their heart rate maintained by left atrial pacing. We found that LTC4 and D4 increased systemic arterial pressure and decreased cardiac output and heart rate. However, LTD,, but not LTC4, increased pulmonary arterial pressure. The hemodynamic effects of LTC4 and LTD4 were completely blocked by FPL57231 but not by phentolamine mesylate. Maintenance of heart rate by left atrial pacing did not alter the LT-induced decrease in cardiac output. We conclude that LTC4 and D4 have similar effects on the systemic circulation. However, LTD4 produces more pulmonary vasoconstriction. Because FPL57231 did block the pulmonary vasoconstriction caused by LT, LT antagonists may be useful in treating patients with pulmonary hypertension. ( Recent studies have shown that LT cause in vitro contraction of smooth muscle in a variety of tissues including trachea (1-4), lung (1, [3] [4] [5] , uterus (4, 6) , gastrointestinal tract (4, 6, 7) , and blood vessels (1, 3,4, 8-1 1). LT may also play an important role in in vivo vascular smooth muscle contraction (12) (13) (14) (15) (16) (17) (18) . This hypothesis is supported by the finding that the LT receptor antagonist FPL57231 (Fisons, plc, Loughborough, UK) attenuates hypoxia-induced pulmonary vasoconstriction in several animal species (13, 14, 17) . Clinically, LT have been isolated from the lung lavage fluid of patients with either the persistent pulmonary hypertension of the newborn syndrome (19) or the adult respiratory distress syndrome (20, 2 1).
The specific LT that cause pulmonary vasoconstriction and other types of smooth muscle contraction are L T C and LTD4, both C-6 peptide derivatives of LTA4. L T C is converted to LTD4 through peptidolysis (6) . Several previous studies have shown LTD4 to be a potent in vivo pulmonary vasoconstrictor (1 2, 18,22,23). Evidence suggests that LTC4 is also a pulmonary vasoconstrictor (3, 1 1, 16, 24) . If LT do mediate the pulmonary vasoconstriction seen in some disease states, then LTC4 and LTD4 may play equal roles, or one may predominate.
In this study, we first wanted to determine whether L T C and LTD4 produce equal pulmonary and systemic circulatory effects. We therefore performed dose-response studies of L T C and LTD4 on spontaneously breathing newborn lambs.
It is possible that the pulmonary and systemic vasoconstriction produced by LT are mediated through other substances. To investigate whether the hemodynamic effects of LT are mediated through LT receptor stimulation or a-adrenergic stimulation (25) , we treated some lambs with FPL57231, a LT receptor antagonist, or phentolamine mesylate, an a-adrenergic antagonist, before injecting LT.
Although previous studies had suggested that LT decrease cardiac output without affecting heart rate (9, 26, 27) , our preliminary data (28) showed a decrease in heart rate. To determine whether the LT-induced decrease in cardiac output was caused by the decrease in heart rate, we injected LT into lambs whose heart rates were maintained using atrial pacing.
METHODS

Surgical preparation.
Sixteen newborn lambs at 1 to 3 days of age were operated on under local anesthesia induced by 1% lidocaine hydrochloride. Polyvinyl catheters were placed in a hind leg artery and vein and advanced to the descending aorta and inferior vena cava, respectively. General anesthesia was induced by having the lamb breathe a mixture of oxygen and isoflurane. The lamb was then intubated with a 4.5 mm OD endotracheal tube and mechanically ventilated with a Harvard animal ventilator.
A left lateral thoracotomy was performed in the fourth or fifth intercostal space. Polyvinyl catheters were placed in the internal thoracic artery and vein and advanced to the ascending aorta and superior vena cava (central venous), respectively. The pericardium was incised along the main pulmonary trunk. Teflon cannulae attached to polyvinyl catheters were inserted into the main pulmonary artery and left atrium. A calibrated electromagnetic flow transducer (CC Instruments, Los Angeles, CA) was placed around the main pulmonary artery to measure cardiac L T G AND LTD4 IN NEWBORN LAMBS 177 output. In four of the 16 newborn lambs, bipolar stainless steel pacing electrodes were sewn onto the epicardial surface of the left atrial appendage. A chest tube was placed in the pleural space. The catheters were filled with heparin, plugged, and, along with the transducer cable and pacing wires, brought to the skin, where they were protected in a pouch sewn to the lamb's flank. The thoracotomy incision was closed in layers. The lamb was weaned from mechanical ventilation, extubated, and, after recovery from anesthesia, returned to its mother. An intramuscular injection of 1 ml of penicillin G procaine and dihydrostreptomycin sulfate suspension was given daily. Three days were allowed for recovery.
LTC4 and LTD4 dose-responses. Lambs were randomly given selected doses (0.0 1, 0.1, 0.25, 0.5, 1 .O, 2.0 pg/kg) of L T C or LTD, by bolus injection into the inferior vena cava. Five lambs received all six doses. Seven other lambs received a limited number of the higher doses (Tables 1 and 2 ). Immediately before each LT injection, while the lamb was breathing spontaneously and resting in a sling, the hemodynamic variables (heart rate, pulmonary and systemic arterial pressures, left atrial and central venous pressures, and cardiac output) and systemic arterial pH and blood gases were measured. After each LT injection the hemodynamic variables were again measured at the maximum response, and systemic arterial pH and blood gases were measured at 1-3 min after the injection. Twenty min were allowed for recovery before the administration of the next dose. Preliminary data showed that the response to LT was reproducible only after waiting 20 min between injections.
In three lambs, LT were injected into the left atrium. Injections of the vehicle caused no hemodynamic changes.
L T injection during L T receptor antagonism. To determine if the LT receptor antagonist FPL57231 blocks all the in vivo hemodynamic effects of LTD4, five lambs were also pretreated with FPL5723 1 before LTD4 was injected.
Control measurements were made while the lamb was breathing spontaneously and resting in a sling. LTD4 (0.5 pg/kg) was then injected and the effects were recorded. After at least 20 min, measurements were repeated. An intravenous infusion of FPL57231, 2 mg/kg/min, a dose previously shown to reverse hypoxia-induced pulmonary vasoconstriction in newborn lambs (17) , was started and continued for 10 min. After 5 min of the infusion, 0.5 j~g/kg of LTD4 was again injected and the effects were recorded. The infusion of FPL5723 1 was then stopped. To determine the effectiveness of FPL5723 1 at higher doses of LTD4, the same protocol was also used (in four of the five lambs) for injections of 2.0 pg/kg of LTD4 after waiting 1-2 h until all hemodynamic variables had returned to control.
L T injection during a-adrenergic antagonism. To determine if the a-adrenergic antagonist phentolamine mesylate blocks the hemodynamic effects of LT, three other lambs were pretreated with phentolamine mesylate before LT were injected.
Control measurements were made while the lamb was breathing spontaneously and resting in a sling. L T C or LTD4 (0.5 pg/ kg) was then injected into the inferior vena cava and the effects were recorded. After 20 min, the other LT was injected. An intravenous injection of phentolamine mesylate, 2 mg, a dose with which we blocked the hemodynamic effects of phenylephrine hydrochloride, 2 j~g/kg, was then given. L T C (0.5 j~g/kg) or LTD4 (0.5 pg/kg) was again injected. After 20 min, the other LT was again injected. Prior to and after LT injections, phenylephrine hydrochloride, 2 pg/kg, was injected to confirm adequate a-adrenergic blockade.
L T injection during left atrial pacing. To determine if the LTinduced decrease in cardiac output was caused by the decrease in heart rate, four lambs had their heart rates maintained using left atrial pacing when LT were injected.
Control measurements were made while the Iamb was breathing spontaneously and resting in a sling. L T C or LTD4 (0.5 j~g/ kg) was then injected into the inferior vena cava and the hemoDrugpreparation. In all experiments, L T C and LTD4 (Merck dynamic effects recorded. After 20 min, the other LT was in-Frosst Canada, Inc., Dorval, Quebec, Canada), stored under jected. Left atrial pacing was then begun using an SD5Z electrical nitrogen, were removed from a -70" C freezer, thawed, and stimulator (Grass Medical Instruments, Quincy, MA), at a heart diluted in normal saline immediately before use. FPL5723 1 was rate similar to control heart rate. Hemodynamic measurements prepared immediately before each experiment as a 1 % solution were again recorded. L T C (0.5 &kg) or LTD4 (0.5 ~g/kg) was in sterile water. again injected. After 20 min the other LT was again injected.
Measurements and analyses. 
The means and SDs were calculated for hemodynamic variables (including pulmonary and systemic vascular resistances) and systemic arterial pH and blood gases before and after each injection of L T C and LTD4. The difference for each variable before and after injection was compared by paired t test (29) . The difference between the effects of L T C and LTD4 at each dose was compared by unpaired t tests and linear regression analysis (29) . The effects of FPL57231 infusion and left atrial pacing on responses to L T C and LTD4 were compared using two-way analysis of variance and the Newman-Kuels test for multiple comparisons. A p < 0.05 was considered statistically significant. 
RESULTS
Effects of LTD4 injection. LTD4 caused a dose-dependent increase in pulmonary arterial pressure, pulmonary vascular resistance, systemic arterial pressure, and systemic vascular resistance. These changes were accompanied by decreases in cardiac output and heart rate ( Figs. 1 and 2 ; Table 1 Fig. 3 . FPL5723 1, a LT end-organ antagonist, completely blocks the increases in pulmonary arterial (upper) and systemic arterial (middle) pressures and the decrease in cardiac output (hotloin) caused by injection of LTD4 in the newborn lamb. pressure and central venous pressure (Table 1) . The maximal change in left atrial and central venous pressures occurred later, approximately 45-60 s after injection. All hemodynamic variables returned to baseline within 10 min, taking longer at the higher doses. These hemodynamic changes caused no significant change in systemic arterial pH or blood gases. For example, prior to injecting 2.0 pg/kg of LTD, (highest does injected), systemic arterial pH was 7.39 f 0.06, Pa02 was 73.7 f 10.9 mm Hg, and PaC02 was 44.1 +. 3.6 mm Hg. After the injection, systemic arterial pH was 7.38 f 0.05, Pa02 was 75.7 f 10.6 mm Hg, and PaC02 was 44.7 f 4.6 mm Hg. Left atrial injections produced similar changes in systemic arterial pressure, cardiac output, and heart rate to inferior vena cava injections. However, they produced only minimal changes in pulmonary arterial pressure, likely due to dilution in the systemic circulation. Table 2 ). Although there were significant differences ( p < 0.05) between the effects of LTD, and L T C on pulmonary arterial pressure, there were no significant differences between the slopes or y-intercepts of the linear regression lines for the effects of LTD4 and L T C on systemic arterial pressure and cardiac output. The time courses of these changes and their return to baseline were also remarkably similar to those caused by LTD,. These hemodynamic changes caused no significant changes in systemic arterial pH or blood gases. L T injection during L T receptor antagonism. FPL5723 1 caused no change in the baseline hemodynamic variables, systemic arterial pH, or blood gases. It did, however, completely block all of the hemodynamic changes caused by LTD4 at 0.5 pg/kg (data not shown) and at 2.0 pg/kg (Fig. 3) .
L T injection during a-adrenergic antagonism. Phentolamine mesylate did not change baseline pulmonary arterial pressure, systemic arterial pressure, or cardiac output (Table 3) . It did increase heart rate. The responses to L T C and LTD4 injections were not altered by treatment with phentolamine mesylate. The increase in pulmonary and systemic arterial pressures and decrease in cardiac output were similar before and after trea..nent with phentolamine mesylate. Prior to pheritolamine mesylate, LTD, caused a 25% decrease and LTC, a 27% decrease in heart Table 3 . Hernodynamic efSects of LTC4 and LTD, before Baseline rate. Injection of LTD4 and L T C after phentolamine mesylate still caused a 26 and 25% decrease in heart rate, respectively. L T injection during left atrialpacing. Left atrial pacing did not change baseline pulmonary and systemic arterial pressures, central venous and left atrial pressures, or cardiac output (Table 4) . The responses to LTC, and LTD4 injections were not altered by maintaining the heart rate by left atrial pacing (Table 4) . Therefore, the increase in pulmonary and systemic arterial pressures and decrease in cardiac output were similar whether the heart rate decreased or was maintained by left atrial pacing.
DISCUSSION
The results of our study indicate that in newborn lambs, although LTD, and L T C have very similar effects on the systemic circulation (increasing systemic arterial pressure and decreasing cardiac output), LTD, produces more pulmonary vasoconstriction. This study further suggests that neither the systemic nor the pulmonary hemodynamic effects of LT are mediated through a-adrenergic stimulation. The hemodynamic effects of LT are, however, completely blocked by the LT receptor antagonist FPL5723 1. The marked decrease in cardiac output produced by LT is not caused by the decrease in heart rate, as maintaining the heart rate by left atrial pacing does not alter the decrease in cardiac output.
Although numerous studies have investigated the in vitro effects of LT, few studies have investigated their in vivo hemodynamic effects (12, 18, 22, 23) . In one study (23) comparing L T C to LTD4 in anesthetized, mechanically ventilated newborn piglets, a relationship similar to that seen in our study on the pulmonary circulation was found. However, LTD, had greater effects than L T C on the systemic circulation as well. These findings suggest that conversion of L T C to LTD, provides an overall increase in the degree of vasoconstriction in both the pulmonary and systemic circulations. This difference from our study may be very important. Our study indicates that conversion of LTC4 to LTD, would maintain a similar degree of systemic vasoconstriction and adds potent pulmonary vasoconstriction. The reason for these differences between studies is unclear.
It is unlikely that the effects of L T C seen in our study were caused by conversion of L T C to LTD4 in the lung. If conversion of L T C to LTD, in the lung was required to cause the observed changes in the systemic circulation, left atrial injections of LTC, would cause hemodynamic effects only after circulating through the lung and would thus have a slight delay in the onset of hemodynamic changes. We injected LTD4 and L T C into the left atrium in three lambs. The systemic hemodynamic response was identical to that seen with inferior vena cava injections. Conversion of L T C to LTD, by the lung is, therefore, not required to cause hemodynamic effects.
The circulatory effects of LTD4 alone have been studied in young lambs (18) and adult sheep (12) . In these studies, LTD4 caused similar dose-dependent increases in pulmonary and systemic arterial pressures and decrease in cardiac output. Although some caution must be used when comparing the effects of LTD4 on pulmonary and systemic vascular resistances reported herein with those reported by Yokachi et al. (18) , because they did not measure left or right atrial pressures, remarkably similar results were found. After an injection of 1 .O ~g / k g of LTD4 pulmonary vascular resistance increased 257% in our study and 240% in the Yokachi study. Similarly, systemic vascular resistance increased 1 13% in our study and 1 18% in the Yokachi study. Comparison to the results found in the Ahmed study (12) are more difficult as they measured cardiac output (thermodilution technique) and pulmonary artery wedge pressure at fixed times rather than at maximal response. However, both studies (12, 18) describe a biphasic response of systemic vascular resistance: an initial decrease in resistance followed by a marked increase. A biphasic response was not a consistent finding in our study; it occurred in only six of the 16 lambs. The reason for this variability is unclear.
The decrease in cardiac output produced by the injection of leukotrienes may be due to: 1) a decrease in preload, 2) a decrease in heart rate, 3) an increase in afterload, or 4) a decrease in myocardial contractility. A decrease in preload did not mediate the decrease in cardiac output as both left and right atrial pressures increased. Our results demonstrated a decrease in heart rate. However, there was no attenuation ofthe decrease in cardiac output when heart rate was maintained during left atrial pacing. This shows that the decreased heart rate did not cause the decrease in cardiac output produced by LT. The results of our study, using bolus injections of LT, cannot determine whether the decrease in cardiac output is caused by an increase in afterload or a decrease in contractility. In our study, afterload, as measured by calculated systemic vascular resistance, is increased by the injection of LT. A similar increase in afterload produced by the injection of methoxamine in newborn lambs (25) caused a similar decrease in cardiac output. Injection of LTD4 into the coronary arteries of sheep (9), guinea pigs (26) , and dogs (27) causes a decrease in myocardial contractility as demonstrated by a decrease in left ventricular pressure and dP/ dt. This effect is in part caused by coronary artery vasoconstriction (9) . In our preliminary studies, injection of LTD4 into the inferior vena cava of newborn lambs also caused a decrease in dP/dt, suggesting a decrease in myocardial contractility. Because the effects of bolus injections of LTD4 are so transient, further studies on myocardial performance and metabolism during continuous infusions of LTD4 are needed.
The possible importance of LT in the control of the pulmonary circulation was first suggested in experiments using LT receptor antagonists. FPL5723 1 has recently been shown to attenuate hypoxia-induced pulmonary vasoconstriction in newborn lambs (17) , piglets (14) , and adult sheep (13) . FPL57231 also inhibits )re and durina left atrial ~acina /mean -1-SD: fn = 411 LT Pacing LT during pacing hypoxic pulmonary vasoconstriction in the perfused rat lung. The concentration used was greater than the concentration required to antagonize LTD4 on strips of guinea pig ileum (3 1). In the fetal lamb, both FPL5723 1 and FPL557 12, the parent compound of FPL57231, increase pulmonary blood flow and decrease pulmonary vascular resistance (30) . The results of our study clearly demonstrate that FPL5723 1 also prevents the pulmonary and systemic hemodynamic changes caused by the direct injection of LT in vivo.
Previous studies have suggested that LT may mediate the pulmonary vasoconstriction seen in patients with persistent pulmonary hypertension syndrome (19) and with the adult respiratory distress syndrome (20,2 l), and in laboratory animals during hypoxia (15) . The results of our present study suggest that LTD4 produces more pulmonary vasoconstriction than LTC4. Our results also show that the LTD4 effects are blocked by FPL5723 1. The ability of this LT receptor antagonist to block the LTinduced pulmonary vasoconstriction may have therapeutic implications in those diseases in which LT may play a significant pathological role.
